Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Mood Disorders | Research article

Resilience and health-related quality of life in patients with pulmonary diseases receiving ambulatory oxygen therapy

Authors: Siiri Isokääntä, Kirsi Honkalampi, Hannu Kokki, Harri Sintonen, Merja Kokki

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Pulmonary diseases affect health-related quality of life (HRQoL), but there are few data on patients’ adaptation to a serious illness. This study assessed resilience and its associations with HRQoL, life satisfaction, anxiety and depression in patients with pulmonary diseases receiving ambulatory oxygen therapy.

Methods

In this prospective cohort study, we enrolled 42 patients with pulmonary diseases receiving ambulatory oxygen therapy. The patients completed the following questionnaires at baseline and after one and three months; the Resilience Scale-25, the Life Satisfaction Scale-4, the 15D instrument of HRQoL, the Hospital Anxiety and Depression Scale (HADS) and the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0). To compare HRQoL, we recruited age- and gender-matched controls from the general population (n = 3574). The primary outcome was the proportion of patients with low resilience.

Results

Half (42–48%) of the patients had low resilience, which was correlated with low HRQoL, low levels of life satisfaction and higher levels of anxiety and depression. Patients had very low HRQoL compared to controls. Dissatisfaction with life increased during the 3-months follow-up, but only a few patients had anxiety or depression. Patient satisfaction with assistive technology was high; the median QUEST 2.0 score (scale 1–5) was 4.00 at baseline, 3.92 at one month and 3.88 at three months.

Conclusions

Resilience was low in half of the patients with pulmonary diseases receiving ambulatory oxygen therapy. Higher resilience was positively correlated with HRQoL and life satisfaction and negatively correlated with anxiety and depression.
Trial registration: ClinicalTrials.gov Protocol Record 507A023. Registered 17 September 2020—Retrospectively registered, https://​clinicaltrials.​gov/​ct2/​results?​cond=​&​term=​NCT04554225&​cntry=​&​state=​&​city=​&​dist=​.
Literature
1.
go back to reference Keuhkoahtaumatauti [Chronic obstructive pulmonary disease, Internet]. Helsinki: Suomalainen Lääkäriseura Duodecim, 2020, Finnish [updated 2020 Apr 29, cited 2020 May 20]. Available from: www.kaypahoito.fi/hoi06040#K1. Keuhkoahtaumatauti [Chronic obstructive pulmonary disease, Internet]. Helsinki: Suomalainen Lääkäriseura Duodecim, 2020, Finnish [updated 2020 Apr 29, cited 2020 May 20]. Available from: www.​kaypahoito.​fi/​hoi06040#K1.
9.
go back to reference Hardinge M, Annandale J, Bourne S, Cooper B, Evans A, Freeman D, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax. 2015;70(Suppl 1):i1-43.CrossRef Hardinge M, Annandale J, Bourne S, Cooper B, Evans A, Freeman D, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax. 2015;70(Suppl 1):i1-43.CrossRef
11.
go back to reference Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating bronchitis and emphysema. Lancet. 1980;1(8222):681–6. Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating bronchitis and emphysema. Lancet. 1980;1(8222):681–6.
15.
go back to reference Wagnild GM, Young HM. Development and psychometric evaluation of the resilience scale. J Nurs Meas. 1993;1(2):165–78.PubMed Wagnild GM, Young HM. Development and psychometric evaluation of the resilience scale. J Nurs Meas. 1993;1(2):165–78.PubMed
17.
go back to reference Losoi H, Turunen S, Wäljas M, Helminen M, Öhman J, Julkunen J, et al. Psychometric properties of the Finnish version of the Resilience Scale and its short version. Psychol Commun Health. 2013;2(1):1–10.CrossRef Losoi H, Turunen S, Wäljas M, Helminen M, Öhman J, Julkunen J, et al. Psychometric properties of the Finnish version of the Resilience Scale and its short version. Psychol Commun Health. 2013;2(1):1–10.CrossRef
20.
go back to reference Koskinen S, Lundqvist A, Ristiluoma N. Health, functional capacity and welfare in Finland in 2011. Helsinki: National Institute for Health and Welfare (THL); 2012. (Report 2012;68). Koskinen S, Lundqvist A, Ristiluoma N. Health, functional capacity and welfare in Finland in 2011. Helsinki: National Institute for Health and Welfare (THL); 2012. (Report 2012;68).
30.
go back to reference Patana P. Mental health analysis profiles (MhAPs): Finland. Paris: OECD Publishing; 2014. (No. 72). Patana P. Mental health analysis profiles (MhAPs): Finland. Paris: OECD Publishing; 2014. (No. 72).
32.
go back to reference Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD, 2017. (Report 2017). Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD, 2017. (Report 2017).
34.
go back to reference Koskela H. Pitkäaikainen happihoito:paljon toiveita, vähän näyttöjä [Long term oxygen therapy: many hopes, little proof]. Duodecim. 2009;125(11):1177–83. Koskela H. Pitkäaikainen happihoito:paljon toiveita, vähän näyttöjä [Long term oxygen therapy: many hopes, little proof]. Duodecim. 2009;125(11):1177–83.
Metadata
Title
Resilience and health-related quality of life in patients with pulmonary diseases receiving ambulatory oxygen therapy
Authors
Siiri Isokääntä
Kirsi Honkalampi
Hannu Kokki
Harri Sintonen
Merja Kokki
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01515-5

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.